In addition, hypermethylation of RPRM related to ERα (ESR1) has been observed in several cancers such as breast cancer [74,75,76,77], which is overexpressed in cells treated with BPA in the present study, and even more so in treatments with naringenin + BPA, FEN, and FEN + BPA. This evidence concerns the gene ESR1 and breast cancer.